1 option
Icatibant for Patients with Type III Hereditary Angioedema : The purpose of this report is to review the clinical effectiveness and safety of icatibant when it is used in patients with Type III HAE. This report is an update of a previous CADTH Rapid Response report (2014),15 which found inconclusive evidence from two observational studies to support the use of icatibant in Type III HAE patients / Nazila Assasi.
- Format:
- Book
- Author/Creator:
- Assasi, Nazila Assasi, author.
- Language:
- English
- Subjects (All):
- Clinical medicine.
- Clinical trials.
- Political planning.
- Physical Description:
- 1 online resource (20 pages)
- Place of Publication:
- Canada : Canadian Agency for Drugs and Technologies in Health, 2017.
- Summary:
- The purpose of this report is to review the clinical effectiveness and safety of icatibant when it is used in patients with Type III HAE. This report is an update of a previous CADTH Rapid Response report (2014),15 which found inconclusive evidence from two observational studies to support the use of icatibant in Type III HAE patients.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.